2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD

Publication Title

AHA, Know Diabetes by Heart

Document Type

Presentation

Publication Date

10-28-2020

Abstract

Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.

Clinical Institute

Cardiovascular (Heart)

Clinical Institute

Kidney & Diabetes

Specialty

Cardiology

Specialty

Endocrinology


Share

COinS